MORE FRANKINCENSE RESEARCH INFORMATION

In 2013, the University of Leicester published a press release stating the Omani government-funded research which (for the first time) uncovered that frankincense has the ability to target cancer cells in late-stage ovarian cancer patients. And this all appeared to be due to AKBA (acetyl-11-keto-beta-boswellic acid). (Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med 2006; 72(12): 1100-16.)

According to lead researcher Kamla Al-Salmani,

“After a year of studying the AKBA compound with ovarian cancer cell lines in vitro, we have been able to show it is effective at killing the cancer cells. Frankincense is taken by many people with no known side effects. This finding has enormous potential to be taken to a clinical trial in the future and developed into an additional treatment for ovarian cancer.”

While we do know that the various forms of frankincense benefits (essential oils, extracts, pure resin, etc.) have the potential to fight cancer, much is left to be understood, making this a controversial topic in the natural health and research world.

Current research demonstrates anti-mutagenic and apoptotic (programmed cell death) abilities. Though the results have occurred in lab tests and we have yet to see how to best replicate these results in active cancer in humans, the demonstrated results remain. Researchers found that boswellic acids are “cytotoxic to ovarian cancer cells at pharmacologically achievable concentrations” and “may form the basis of a novel anticancer treatment for ovarian cancer, perhaps alongside conventional chemotherapy.” (https://naturallivingfamily.com/frankincense-oil-benefits/)

You'll feel confident you're getting the purest frankincense essential oil when you use doTerra, known for its superior testing, purity, and therapeutic value.

You can get your frankincense here: mydoterra.com/bethblake